Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant protein C modulation of vasoreactivity in septic shock
2007-002319-16Phase 4Active
- Sponsor
- CHRU Nancy
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of drotrecogin alfa in septic shock and sepsis, sponsored by CHRU Nancy. Started Jul 2007; status: active.
02
Drugs
drotrecogin alfa
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on 2007-002319-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002319-16.